Harvard Bioscience, Inc.
HARVARD BIOSCIENCE INC (Form: 3, Received: 11/01/2017 17:11:44)
FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Eade Katherine A.

2. Date of Event Requiring Statement (MM/DD/YYYY)
10/24/2017 

3. Issuer Name and Ticker or Trading Symbol

HARVARD BIOSCIENCE INC [HBIO]

(Last)        (First)        (Middle)

84 OCTOBER HILL RD.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

HOLLISTON, MA 01746       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Remarks:
No securities are beneficially owned. Exhibit List: Exhibit 24 - Limited Power of Attorney. This form is signed under power of attorney.
No securities are beneficially owned.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Eade Katherine A.
84 OCTOBER HILL RD.
HOLLISTON, MA 01746
X



Signatures
/s/ Chad Porter, by power of attorney 11/1/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
        Exhibit 24



LIMITED POWER OF ATTORNEY

        Katherine A. Eade, hereby appoints Burns & Levinson LLP of Boston,
Massachusetts, acting through its designated attorneys and paralegals, to be the
true and lawful attorney-in-fact (his "Attorney") in his name and on his behalf
to:

      (1)       prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5
(including any amendments thereto) with respect to the securities of Harvard
Bioscience, Inc., a Delaware corporation (the "Company"), with the United States
Securities and Exchange Commission, any national securities exchanges and the
Company, all as considered necessary or advisable under Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations promulgated
thereunder, as amended from time to time (the "Exchange Act");

      (2)        seek or obtain, as the undersigned's representative and on the
undersigned's behalf, if necessary or advisable in connection with performing
the acts described in (1) above or under Section 16(a) of the Exchange Act,
information on transactions in the Company's securities from any third party,
including brokers, employee benefit plan administrators and trustees, and the
undersigned hereby authorizes any such person to release any such information to
the undersigned and approves and ratifies any such release of information; and

      (3)       perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing, including, without limitation, the
preparation, execution and filing of SEC Form ID's with the United States
Securities and Exchange Commission.

The undersigned acknowledges that:

      (1) this Limited Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in their discretion on information provided to such
attorney-in-fact without independent verification of such information and such
attorney-in-fact may presume that any such information he receives is accurate
and complete and he has no obligation to independently verify such information
and is not responsible for any liability based on the inaccuracy or
incompleteness of such information as it is provided by the undersigned;

      (2) any documents prepared and/or executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Limited Power of Attorney will be in
such form and will contain such information and disclosure as such
attorney-in-fact, in his or her discretion, deems necessary or desirable;

      (3) neither the Company nor such attorney-in-fact assumes (i) any
liability for the undersigned's responsibility to comply with the requirement of
the Exchange Act, (ii) any liability of the undersigned for any failure to
comply with such requirements, or (iii) any obligation or liability of the
undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and


      (4) this Limited Power of Attorney does not relieve the undersigned from
responsibility for compliance with the undersigned's obligations under the
Exchange Act, including without limitation the reporting requirements under
Section 16 of the Exchange Act.

        The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, hereby ratifying all that such attorney-in-fact of, for an on
behalf of he undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney. This Limited Power of Attorney shall remain in
full force and effect until revoked by the undersigned in a signed writing
delivered to such attorney-in-fact.

        This Limited Power of Attorney may be filed with the Securities and Exchange
Commission, any other federal, state or foreign securities regulators, and other
entities as a confirming statement of the authority granted herein.

        IN WITNESS whereof this Limited Power of Attorney has been duly executed this
30th day of October, 2017.

                                                /s/ Katherine A. Eade
                                                __________________________________________
                                                Katherine A. Eade